Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,102.55
(
-0.33%
)
US TECH 100
25,852.40
(
-0.39%
)
Dow Jones
49,390.60
(
-0.11%
)
Brent Oil
91.50
(
-1.25%
)
Bitcoin
76,280.00
(
3.27%
)
News Focus
News Focus
Post# of 517454
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nidan7500

Send PM Follow Ignore
Followers 57
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

nidan7500

Re: Jonjones325 post# 454805

Saturday, 03/23/2024 12:12:50 PM

Saturday, March 23, 2024 12:12:50 PM

Post# of 517454
Excellent post/thinking thanks Jonjones325. FDA - EMA may also see an incentive to move on considering the building academic (as recent re: Stanford Pub.) presents evidence questioning the AD Amyloid thesis. It is truly time for all to move on. . Let AVXL RWD-RWE provide additional evidence CNS treatment efficacy.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News